Organization
Melbourne Health
6 clinical trials
1 abstract
Abstract
Mutated KRAS as a promising target in pancreas cancer: PURPLE registry data to inform real-world incidence and prognostic significance and to aid trial recruitment.Org: Northern Health, Peter MacCallum Cancer Centre, Melbourne, Australia, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Melbourne Health,
Clinical trial
Pegylated Interferon Alfa-2a Plus Ribavirin for Patients With Chronic Hepatitis c Virus on Opioid Pharmacotherapy: Virological and Psychological OutcomesStatus: Completed, Estimated PCD: 2006-01-01
Clinical trial
A Phase 0/2 Study of AB-218 in Patients With IDH1 Mutated Low Grade GliomaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Abatacept Combined With Nasal Insulin to Preserve Beta-cell Function in Recently-diagnosed Type 1 DiabetesStatus: Active (not recruiting), Estimated PCD: 2026-02-13
Clinical trial
Electroconvulsive Therapy and Concomitant Lithium in Depression: a Double-blind Randomized Controlled Pilot StudyStatus: Active (not recruiting), Estimated PCD: 2025-05-30
Clinical trial
The VICTORY Study: A Phase I Study of Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal InfectionStatus: Recruiting, Estimated PCD: 2023-12-30